139 related articles for article (PubMed ID: 20803331)
1. Temporal and illumination-induced variations in the in vivo light transmission spectra of four photosensitizers in EMT6/Ed murine tumours.
Ballangrud AM; Barajas O; Brown K; Miller GG; Moore RB; Tulip J
Lasers Med Sci; 1997 Oct; 12(3):237-44. PubMed ID: 20803331
[TBL] [Abstract][Full Text] [Related]
2. In vivo light transmission spectra in EMT6/Ed murine tumors and Dunning R3327 rat prostate tumors during photodynamic therapy.
Ballangrud AM; Barajas O; Georgousis A; Miller GG; Moore RB; McPhee MS; Tulip J
Lasers Surg Med; 1997; 21(2):124-33. PubMed ID: 9261789
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic activities and skin photosensitivity of the bis(dimethylthexylsiloxy)silicon 2,3-naphthalocyanine in mice.
Brasseur N; Ouellet R; Lewis K; Potter WR; van Lier JE
Photochem Photobiol; 1995 Dec; 62(6):1058-65. PubMed ID: 8570740
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
5.
Zhu TC; Kim MM; Liang X; Finlay JC; Busch TM
Photonics Lasers Med; 2015 Feb; 4(1):59-71. PubMed ID: 25927018
[TBL] [Abstract][Full Text] [Related]
6. Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update.
Miller GG; Brown K; Ballangrud AM; Barajas O; Xiao Z; Tulip J; Lown JW; Leithoff JM; Allalunis-Turner MJ; Mehta RD; Moore RB
Photochem Photobiol; 1997 Apr; 65(4):714-22. PubMed ID: 9114749
[TBL] [Abstract][Full Text] [Related]
7. Distribution of photosensitizers in bladder cancer spheroids: implications for intravesical instillation of photosensitizers for photodynamic therapy of bladder cancer.
Xiao Z; Hansen CB; Allen TM; Miller GG; Moore RB
J Pharm Pharm Sci; 2005 Sep; 8(3):536-43. PubMed ID: 16401399
[TBL] [Abstract][Full Text] [Related]
8. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment.
Korbelik M; Cecic I
J Photochem Photobiol B; 1998 Jul; 44(2):151-8. PubMed ID: 9757597
[TBL] [Abstract][Full Text] [Related]
10. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
11. Parameter Determination for Singlet Oxygen Modeling of BPD-Mediated PDT.
McMillan DD; Chen D; Kim MM; Liang X; Zhu TC
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8568():. PubMed ID: 25999644
[TBL] [Abstract][Full Text] [Related]
12. Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin).
Wolford ST; Novicki DL; Kelly B
Fundam Appl Toxicol; 1995 Jan; 24(1):52-6. PubMed ID: 7713343
[TBL] [Abstract][Full Text] [Related]
13. Hemoporfin-mediated photodynamic therapy on normal vasculature: implications for phototherapy of port-wine stain birthmarks.
Moy WJ; Ma G; Kelly KM; Choi B
J Clin Transl Res; 2016 Sep; 2(3):107-111. PubMed ID: 29226252
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630 nm laser light in canine esophagus.
Panjehpour M; DeNovo RC; Petersen MG; Overholt BF; Bower R; Rubinchik V; Kelly B
Lasers Surg Med; 2002; 30(1):26-30. PubMed ID: 11857600
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells.
Huang Y; Obana A; Gohto Y; Nakajima S
Lasers Surg Med; 2004; 34(3):216-26. PubMed ID: 15022248
[TBL] [Abstract][Full Text] [Related]
16. Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin.
Rousset N; Vonarx V; Eléouet S; Carré J; Bourré L; Lajat Y; Patrice T
Res Exp Med (Berl); 2000 Jun; 199(6):341-57. PubMed ID: 10945652
[TBL] [Abstract][Full Text] [Related]
17. Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation.
Gillies R; Kollias N; Hasan T; Diddens H
J Photochem Photobiol B; 1996 Mar; 33(1):87-90. PubMed ID: 8786464
[TBL] [Abstract][Full Text] [Related]
18. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas.
Cincotta L; Szeto D; Lampros E; Hasan T; Cincotta AH
Photochem Photobiol; 1996 Feb; 63(2):229-37. PubMed ID: 8657737
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
Karotki A; Khurana M; Lepock JR; Wilson BC
Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
[TBL] [Abstract][Full Text] [Related]
20. Hypocrellins as photosensitizers for photodynamic therapy: a screening evaluation and pharmacokinetic study.
Estey EP; Brown K; Diwu Z; Liu J; Lown JW; Miller GG; Moore RB; Tulip J; McPhee MS
Cancer Chemother Pharmacol; 1996; 37(4):343-50. PubMed ID: 8548880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
